Serina Therapeutics (SER) Receivables - Net (2017 - 2024)
Serina Therapeutics (SER) reported Receivables - Net of $65,000 for Q1 2024, up 983.3% from $6,000 a year earlier and up 14.0% from the prior quarter.
Powered by 
Analysis
Serina Therapeutics (SER) Receivables - Net (2017 - 2024) Analysis & Trends
At the end of FY2023, Serina Therapeutics posted Receivables - Net of $57,000.
- Receivables - Net has a five-year compound annual growth rate of -15.3% (FY2018 to FY2023).
- By year, Receivables - Net came in at $4,000 in FY2022 (-84.0%), $25,000 in FY2021 (-92.3%), $326,000 in FY2020 (-10.2%) and $363,000 in FY2019 (+177.1%).
- Five-year quarterly Receivables - Net spans a low of $1,000 in Q3 2022 and a high of $366,000 in Q1 2020.
- Year over year, Receivables - Net gained in two of the last five quarters, with growth averaging 152.5%.
- The high point for year-over-year Receivables - Net in five years was Q1 2024 (growth of 983.3%); the low point was Q3 2022 (a decline of 95.8%).
- Per Business Quant data, the three quarters before Q1 2024 came in at $57,000 (Q4 2023), $67,000 (Q3 2023) and $6,000 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Serina Therapeutics | 29.17 Mn | -11.58 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 57,000.00 |
| Sep 30, 2023 | 67,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2022 | 12,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 48,000.00 |
| Dec 31, 2020 | 326,000.00 |
| Sep 30, 2020 | 241,000.00 |
| Jun 30, 2020 | 235,000.00 |
| Mar 31, 2020 | 366,000.00 |
| Dec 31, 2019 | 363,000.00 |
| Sep 30, 2019 | 234,000.00 |
| Jun 30, 2019 | 208,000.00 |
| Mar 31, 2019 | 206,000.00 |
API Access
Serina Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=SER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "SER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=SER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();